Pharma News

Thousand Oaks, California-based Amgen is acquiring Seattle-based Rodeo Therapeutics.

The National Institute for Health and Care Excellence (NICE) has recommended Sobi’s Kineret for the first-line treatment of the rare inflammatory disorder Still’s disease.

The European Commission (EC) has approved Roche’s spinal muscular atrophy (SMA) treatment Evrysdi for use in patients aged two months and older.

Just over a year after Wave Life Sciences cut staffers, threw out a Duchenne muscular dystrophy med and saw its Huntington's disease drug flop in a key test, the waves come crashing down again for...

Merck is having a very busy week.

A new coronavirus strain has been identified in Israel, the Health Ministry said on Tuesday, and the Pfizer/BioNTech vaccine, used primarily in a swift nationwide inoculation drive, appeared to be eff...

ZURICH (Reuters) - Novartis is laying off 400 people and closing a U.

TOKYO, Japan I March 26, 2021 - Astellas Pharma Inc.

A new type of cancer immunotherapy, when added to Bristol Myers Squibb's drug Opdivo, succeeded in a late-stage clinical study of people with melanoma that's spread and can't be surgically...

GSK–VirGlaxoSmithKline and Vir Biotechnology have filed for emergency use authorization (EUA) for VIR-7831 (GSK4182136), a dual-action SARS-CoV-2 monoclonal antibody.

The FDA has approved idecabtagene vicleucel for the treatment of adult patients with relapsed or refractory multiple myeloma after 4 or more prior therapies, including an immunomodulatory drug, a prot...

The FDA has updated the label of GlaxoSmithKline's shingles vaccine Shingrix to include language about increased risk of the rare neuro autoimmune disorder Guillain-Barré Syndrome.